🇺🇸 SECExascale Labs Holdings Inc.Codex · 实盘不做把握 4/10不做原因:无增量信息
北京时间·🕒 发布 00:35:12·⟳ 抓取 00:35:42 +30s·⚡ 决策 09-09 00:43:09 +7m27s·49.0 天前
Exascale Labs 任命临时 CFO,但未见经营层新增实质信息
该 8-K 只是人事补位和雇佣条款披露,不改变公司收入、利润、订单、融资或监管状态,且没有足够强的方向性边际来支持交易。
📄 原文Exascale Labs Holdings Inc.↗ 原文
----- exascalelabs_8k.htm ----- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURREN…
不做 Exascale Labs Holdings Inc.(XLAB.US)
仅为临时 CFO 任命,缺乏可交易的新增经营或财务事实。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
结论摘要
事实层面是临时 CFO 任命,协议条款也很轻;影响链只触及财务岗位交接,不触及经营和估值核心变量。市场上可见的交易标的只有 XLAB.US,但这类公告通常不足以提供正负 edge,因此不做。
🔎 新鲜度:最早出现 2026-09-08 · 扩散 low · price-in 风险 low ↗
消息传播链
- 官方 8-K 首次披露临时 CFO 任命及咨询协议条款,属于人事信息而非经营信息。
关键理由
- 公告没有披露任何会改变短期业绩预期的经营信息。
- 临时 CFO 任命属于治理补位,通常不足以驱动可交易重估。
- 咨询费和任期安排都偏轻,不构成资本结构或现金流冲击。
主要风险
- 若后续披露 CFO 离任伴随重述、融资或内控问题,性质会显著变重。
- 公司刚完成上市整合,管理层稳定性仍可能被市场放大解读。
反向证据
- 做多前查反向 · 来源 web · 日期 2026-09-08 · 影响 none
未找到任何与本次任命直接绑定的业绩上调、订单或融资增量。
检索:XLAB 临时 CFO 任命 是否伴随收入指引 上调 订单 融资 或 重述 原文 ↗
先例如何影响了这次决策
对本次决策的影响:先例不足,不影响最终 AVOID。
方向:未找到足够高相似、可交易的先例来改变方向判断。
涨幅量级:此类临时 CFO 变动通常缺乏可比的经营增量,无法据先例校准幅度。
形态:无可用样本支持明显见光死或持续重估模式。
工具执行结果 · 成功 2 · 降级 0 · 失败 0 · 取消 0
- web_search 成功 ? · 0 ms
- web_search 成功 ? · 0 ms
原文全文
展开原文 · 6,747 字
----- exascalelabs_8k.htm -----
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
September 4, 2026
EXASCALE LABS HOLDINGS INC.
(Exact name of registrant as specified in charter)
Delaware
001-43465
42-3035215
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
820 Gessner Road
,
Suite 332
Houston
,
TX
77024
(Address of principal executive offices) (Zip Code)
(650)
537-7553
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Class A Common Stock, $0.0001 par value per share
XLAB
The Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50
XLABW
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On
September 4, 2026, Exascale Labs Holdings Inc. (the “Company”) appointed Gildas Bonnier as Interim Chief Financial Officer
of the Company, effective as of September 4, 2026. In his position as Interim Chief Financial Officer, Mr. Bonnier will act as the Company’s
“principal financial officer” while a formal search process to identify and appoint a permanent Chief Financial Officer of
the Company is conducted. Mr. Bonnier will be reporting to the Chief Executive Officer of the Company and will be subject to the oversight
of the Audit Committee of the Board of Directors of the Company.
Gildas
Bonnier, 51, has more than 20 years of experience in P&L oversight, strategic planning, margin improvement, cost optimization, and
execution in capital-intensive businesses in the industrial infrastructure sector. From 2003 to 2024, Mr. Bonnier held progressively
senior roles at Air Liquide. As Business Development Director, Hydrogen Energy (2021–2024), Mr. Bonnier managed commercial opportunities
representing a substantial portion of business-unit revenue and gross margin and developed partnerships involving approximately $325
million of contemplated capital investment. As Data Science Group Lead, R&D (2017–2020), Mr. Bonnier led pricing, contract-optimization
and customer analytics initiatives. As Strategic Initiatives and Product Management, Industrial Merchant (2014–2016), Mr. Bonnier
developed the five-year strategic plan for a $900 million business unit, managed performance of a $500 million product line, and led
pricing and asset-utilization initiatives targeting EBIT improvements. Following Air Liquide, in 2025 Mr. Bonnier served as Head of Hydrogen
Sourcing and Partnerships at Nikola Motors, where he led sourcing, commercial restructuring and cost-reduction initiatives. In 2026,
he co-founded Grove Hydrogen Solutions, an infrastructure services venture focused on the operations and maintenance of hydrogen refueling
stations and owners’ representation during project development and execution. Mr. Bonnier holds an MBA in Finance from the Wharton
School, an M.S. in Transportation Infrastructure from École des Ponts ParisTech, and a B.S. in Mechanical Engineering from ESTACA.
In
connection with the appointment of Mr. Bonnier as the Company’s Interim Chief Financial Officer, the Company entered into a consulting
agreement, dated as of September 4, 2026, with Mr. Bonnier (the “Consulting Agreement”). Pursuant to the Consulting Agreement,
the Company will pay Mr. Bonnier a fee of $10,000 per calendar month, prorated for any partial month, payable monthly in arrears. The
foregoing fee constitutes the entirety of Mr. Bonnier’s compensation for his services as the Company’s Interim Chief Financial
Officer. Mr. Bonnier will not be entitled to any bonus, equity award, severance or employee benefits under the Consulting Agreement.
The Company will reimburse Mr. Bonnier for reasonable, documented, out-of-pocket business expenses incurred in connection with the performance
of his/her services, provided that such expenses are approved in advance by the Company’s Chief Executive Officer. The Consulting
Agreement will continue until the earliest of (i) the date a permanent Chief Financial Officer of the Company begins service, (ii) termination
by either party upon ten (10) days’ written notice to the other party or (iii) immediate termination by the Company for fraud,
willful misconduct, gross negligence, material breach of the Consulting Agreement, violation of applicable law or material Company policy,
or refusal to perform the services.
There
are no arrangements or understandings between Mr. Bonnier and any other person pursuant to which Mr. Bonnier was appointed as Interim
Chief Financial Officer of the Company. There are no family relationships between Mr. Bonnier and any director or executive officer of
the Company. There are no current or proposed transactions in which Mr. Bonnier has or will have a direct or indirect material interest
and in which the Company is or will be a participant that requires disclosure pursuant to Item 404 (a) of Regulation S-K.
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: September 8, 2026
EXASCALE LABS HOLDINGS INC.
By:
/s/ Hoansoo Lee
Name:
Hoansoo Lee
Title:
Chief Executive Officer
2
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
September 4, 2026
EXASCALE LABS HOLDINGS INC.
(Exact name of registrant as specified in charter)
Delaware
001-43465
42-3035215
(State or other jurisdiction
of incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
820 Gessner Road
,
Suite 332
Houston
,
TX
77024
(Address of principal executive offices) (Zip Code)
(650)
537-7553
(Registrant’s telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Class A Common Stock, $0.0001 par value per share
XLAB
The Nasdaq Stock Market LLC
Warrants, each whole warrant exercisable for one Class A Common Stock at an exercise price of $11.50
XLABW
The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On
September 4, 2026, Exascale Labs Holdings Inc. (the “Company”) appointed Gildas Bonnier as Interim Chief Financial Officer
of the Company, effective as of September 4, 2026. In his position as Interim Chief Financial Officer, Mr. Bonnier will act as the Company’s
“principal financial officer” while a formal search process to identify and appoint a permanent Chief Financial Officer of
the Company is conducted. Mr. Bonnier will be reporting to the Chief Executive Officer of the Company and will be subject to the oversight
of the Audit Committee of the Board of Directors of the Company.
Gildas
Bonnier, 51, has more than 20 years of experience in P&L oversight, strategic planning, margin improvement, cost optimization, and
execution in capital-intensive businesses in the industrial infrastructure sector. From 2003 to 2024, Mr. Bonnier held progressively
senior roles at Air Liquide. As Business Development Director, Hydrogen Energy (2021–2024), Mr. Bonnier managed commercial opportunities
representing a substantial portion of business-unit revenue and gross margin and developed partnerships involving approximately $325
million of contemplated capital investment. As Data Science Group Lead, R&D (2017–2020), Mr. Bonnier led pricing, contract-optimization
and customer analytics initiatives. As Strategic Initiatives and Product Management, Industrial Merchant (2014–2016), Mr. Bonnier
developed the five-year strategic plan for a $900 million business unit, managed performance of a $500 million product line, and led
pricing and asset-utilization initiatives targeting EBIT improvements. Following Air Liquide, in 2025 Mr. Bonnier served as Head of Hydrogen
Sourcing and Partnerships at Nikola Motors, where he led sourcing, commercial restructuring and cost-reduction initiatives. In 2026,
he co-founded Grove Hydrogen Solutions, an infrastructure services venture focused on the operations and maintenance of hydrogen refueling
stations and owners’ representation during project development and execution. Mr. Bonnier holds an MBA in Finance from the Wharton
School, an M.S. in Transportation Infrastructure from École des Ponts ParisTech, and a B.S. in Mechanical Engineering from ESTACA.
In
connection with the appointment of Mr. Bonnier as the Company’s Interim Chief Financial Officer, the Company entered into a consulting
agreement, dated as of September 4, 2026, with Mr. Bonnier (the “Consulting Agreement”). Pursuant to the Consulting Agreement,
the Company will pay Mr. Bonnier a fee of $10,000 per calendar month, prorated for any partial month, payable monthly in arrears. The
foregoing fee constitutes the entirety of Mr. Bonnier’s compensation for his services as the Company’s Interim Chief Financial
Officer. Mr. Bonnier will not be entitled to any bonus, equity award, severance or employee benefits under the Consulting Agreement.
The Company will reimburse Mr. Bonnier for reasonable, documented, out-of-pocket business expenses incurred in connection with the performance
of his/her services, provided that such expenses are approved in advance by the Company’s Chief Executive Officer. The Consulting
Agreement will continue until the earliest of (i) the date a permanent Chief Financial Officer of the Company begins service, (ii) termination
by either party upon ten (10) days’ written notice to the other party or (iii) immediate termination by the Company for fraud,
willful misconduct, gross negligence, material breach of the Consulting Agreement, violation of applicable law or material Company policy,
or refusal to perform the services.
There
are no arrangements or understandings between Mr. Bonnier and any other person pursuant to which Mr. Bonnier was appointed as Interim
Chief Financial Officer of the Company. There are no family relationships between Mr. Bonnier and any director or executive officer of
the Company. There are no current or proposed transactions in which Mr. Bonnier has or will have a direct or indirect material interest
and in which the Company is or will be a participant that requires disclosure pursuant to Item 404 (a) of Regulation S-K.
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: September 8, 2026
EXASCALE LABS HOLDINGS INC.
By:
/s/ Hoansoo Lee
Name:
Hoansoo Lee
Title:
Chief Executive Officer
2
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。